HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.

Abstract
This is the first ever attempt to combine anti-cancer therapeutic effects of emerging anticancer biodrug bovine lactoferrin (bLf), and multimodal imaging efficacy of Fe3O4 nanoparticles (NPs) together, as a saturated Fe3O4-bLf. For cancer stem cell specific uptake of nanocapsules/nanocarriers (NCs), Fe3O4-bLf was encapsulated in alginate enclosed chitosan coated calcium phosphate (AEC-CP) NCs targeted (Tar) with locked nucleic acid (LNA) modified aptamers against epithelial cell adhesion molecule (EpCAM) and nucleolin markers. The nanoformulation was fed orally to mice injected with triple positive (EpCAM, CD133, CD44) sorted colon cancer stem cells in the xenograft cancer stem cell mice model. The complete regression of tumor was observed in 70% of mice fed on non-targeted (NT) NCs, with 30% mice showing tumor recurrence after 30 days, while only 10% mice fed with Tar NCs showed tumor recurrence indicating a significantly higher survival rate. From tumor tissue analyses of 35 apoptotic markers, 55 angiogenesis markers, 40 cytokines, 15 stem cell markers and gene expression studies of important signaling molecules, it was revealed that the anti-cancer mechanism of Fe3O4-bLf was intervened through TRAIL, Fas, Fas-associated protein with death domain (FADD) mediated phosphorylation of p53, to induce activation of second mitochondria-derived activator of caspases (SMAC)/DIABLO (inhibiting survivin) and mitochondrial depolarization leading to release of cytochrome C. Induction of apoptosis was observed by inhibition of the Akt pathway and activation of cytokines released from monocytes/macrophages and dendritic cells (interleukin (IL) 27, keratinocyte chemoattractant (KC)). On the other hand, the recurrence of tumor in AEC-CP-Fe3O4-bLf NCs fed mice mainly occurred due to activation of alternative pathways such as mitogen-activated protein kinases (MAPK)/extracellular signal-regulated kinases (ERK) and Wnt signaling leading to an increase in expression of survivin, survivin splice variant (survivin 2B) and other anti-apoptotic proteins Bad, Bcl-2 and XIAP. Apart from the promising anti-cancer efficacy and the exceptional tumor targeting ability observed by multimodal imaging using near-infrared (NIR) imaging, magnetic resonance imaging (MRI) and computerized tomographic (CT) techniques, these NCs also maintained the immunomodulatory benefits of bLf as they were able to increase the RBC, hemoglobin, iron calcium and zinc levels in mice.
AuthorsKislay Roy, Rupinder K Kanwar, Jagat R Kanwar
JournalBiomaterials (Biomaterials) Vol. 71 Pg. 84-99 (Dec 2015) ISSN: 1878-5905 [Electronic] Netherlands
PMID26318819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • AC133 Antigen
  • Antigens, CD
  • Antigens, Neoplasm
  • Aptamers, Nucleotide
  • Cadherins
  • Cell Adhesion Molecules
  • Epithelial Cell Adhesion Molecule
  • Ferric Compounds
  • Glycoproteins
  • Oligonucleotides
  • Peptides
  • Prom1 protein, mouse
  • cadherin 5
  • locked nucleic acid
  • ferric oxide
  • Lactoferrin
Topics
  • AC133 Antigen
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Neoplasm (metabolism)
  • Aptamers, Nucleotide (chemistry)
  • Cadherins (metabolism)
  • Cattle
  • Cell Adhesion Molecules (metabolism)
  • Colonic Neoplasms (diagnosis, metabolism)
  • Epithelial Cell Adhesion Molecule
  • Ferric Compounds (chemistry)
  • Gene Expression Profiling
  • Glycoproteins (metabolism)
  • Heterografts
  • Lactoferrin (chemistry)
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Nude
  • Nanostructures
  • Oligonucleotides (chemistry)
  • Peptides (metabolism)
  • Spectroscopy, Near-Infrared
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: